Measurable Residual Disease Response and Prognosis in Treatment-Naive Acute Myeloid Leukemia With Venetoclax and Azacitidine

Erstveröffentlichung
2022Authors
Pratz, Keith W.
Jonas, Brian A.
Pullarkat, Vinod
Recher, Christian
Schuh, Andre C.
Wissenschaftlicher Artikel
Published in
Journal of Clinical Oncology ; 40 (2022), 8. - S. 855-865. - ISSN 0732-183X. - eISSN 1527-7755
Link to publication
https://dx.doi.org/10.1200/JCO.21.01546Institutions
UKU. Klinik für Innere Medizin IIISubject headings
[Free subject headings]: OLDER PATIENTS | AML | RECOMMENDATIONS | DIAGNOSIS | THERAPY | RISK | AGE[DDC subject group]: DDC 610 / Medicine & health